HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity

FASEB J. 2000 Aug;14(11):1629-40. doi: 10.1096/fj.14.11.1629.

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) controls a genetic program known as 'invasive growth', which involves as critical steps cell adhesion, migration, and trespassing of basement membranes. We show here that in MDA-MB-231 carcinoma cells, these steps are elicited by HGF/SF but not by epidermal growth factor (EGF). Neither factor substantially alters the production or activity of extracellular matrix proteases. HGF/SF, but not EGF, selectively promotes cell adhesion on laminins 1 and 5, fibronectin, and vitronectin through a PI3-K-dependent mechanism. Increased adhesion is followed by enhanced invasiveness through isolated matrix proteins as well as through reconstituted basement membranes. Inhibition assays using function-blocking antibodies show that this phenomenon is mediated by multiple integrins including beta1, beta3, beta4, and beta5. HGF/SF triggers clustering of all these integrins at actin-rich adhesive sites and lamellipodia but does not quantitatively modify their membrane expression. These data suggest that HGF/SF promotes cell adhesion and invasiveness by increasing the avidity of integrins for their specific ligands.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / drug effects
  • Actins / metabolism
  • Antibodies / immunology
  • Antibodies / pharmacology
  • Basement Membrane / chemistry
  • Basement Membrane / metabolism
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology*
  • Cadherins / metabolism
  • Cell Adhesion / drug effects
  • Cell Division / drug effects
  • Cell Movement / drug effects*
  • Collagen / metabolism
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Epidermal Growth Factor / pharmacology
  • Extracellular Matrix Proteins / metabolism
  • Gene Expression / drug effects
  • Hepatocyte Growth Factor / pharmacology*
  • Humans
  • Integrins / antagonists & inhibitors
  • Integrins / immunology
  • Integrins / metabolism*
  • Laminin / metabolism
  • Ligands
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness / pathology
  • Phenotype
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Proteoglycans / metabolism
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Actins
  • Antibodies
  • Cadherins
  • Drug Combinations
  • Extracellular Matrix Proteins
  • Integrins
  • Laminin
  • Ligands
  • Phosphoinositide-3 Kinase Inhibitors
  • Proteoglycans
  • matrigel
  • Epidermal Growth Factor
  • Hepatocyte Growth Factor
  • Collagen
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 9